JD Supra

FDA Launches Green List To Simplify Import of Compliant GLP-1 API for Pharmacy Compounding

On Sept. 5, the FDA announced an import alert and green list for glucagon-like peptide-1 (GLP-1) active pharmaceutical ingredient (API) manufacturers. The FDA included manufacturers on the green list ...
JD Supra

FDA Launches “Green List” to Combat Illegal GLP-1 Imports

The U.S. Food and Drug Administration (“FDA”) announced the launch of its “Green List” initiative designed to protect consumers from illegally imported GLP-1 drug ingredients—such as semaglutide and ...
Monthly Prescribing Reference

FDA Creates ‘Green List’ of GLP-1 Drug Ingredients Approved for Entry in the US

Patients are advised to get a prescription from their doctor and to fill the prescription at a licensed pharmacy or use the FDA's BeSafeRx campaign to determine where to safely buy medications online.
Hosted on MSN

FDA ‘green list’ flagging illegal GLP-1RA compounders is long overdue

In the midst of the rising popularity of glucagon-like peptide-1 receptor agonists (GLP-1RAs), and their compounded versions, the US Food and Drug Administration (FDA) has been stepping up its efforts ...